healthprotocol.wiki

way_2016_n1_tresiba-dramatically-lowered-a1c-but-caused-weight-gain-and-infections

5 findings

Protocol
medication-insulin-degludec-tresiba-liraglutide-dual-protocol
Outcome
biomarker-glycated-hemoglobin-a1c-serum-percent-measured
n
1
effect
70
attribution
30
Protocol
medication-insulin-degludec-tresiba-liraglutide-dual-protocol
Outcome
body-composition-weight-increase-from-baseline-kilograms-measured
n
1
effect
-60
attribution
25
Protocol
medication-insulin-degludec-tresiba-liraglutide-dual-protocol
Outcome
gastrointestinal-diarrhea-episodes-per-day-count-self-reported
n
1
effect
-40
attribution
25
Protocol
medication-insulin-degludec-tresiba-liraglutide-dual-protocol
Outcome
infection-uti-occurrence-binary-self-reported
n
1
effect
-40
attribution
25
Protocol
medication-insulin-degludec-tresiba-liraglutide-dual-protocol
Outcome
pain-musculoskeletal-joint-pain-severity-rating-self-reported
n
1
effect
-30
attribution
25